Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

SYSTEMATIC REVIEW BISPECIFIC ANTIBODIES IN RELAPSED REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW OF EFFICACY AND SAFETY IN PHASE I/II/III CLINICAL TRIAL

2024JournalOpen access

10.53555/jptcp.v31i3.4993 Full text0 citations

Authors

8 authors across 9 institutions in 6 countries.

Syed Ahsan Ali ShahFirst author
Vanessa OwireduCorresponding
- University of Ghana (GH)
as printed: Dr. Vanessa Owiredu
Abhijeet Kumar
Amgad Samir Abdelmageed Mohamed Elfeki
- Egyptian Russian University (EG)
- Egyptian Government (EG)
Faryal Tariq
Zacarius William Seit
Shams Almallah
Mohammad AlhajriSenior author

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Multiple Myeloma Research and Treatmentslevel 3 · 1.00
Monoclonal and Polyclonal Antibodies Researchlevel 3 · 0.99
Synthesis and Biological Evaluationlevel 3 · 0.93

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 10, 2026
2024 · 0 citations
https://openalex.org/W4392810766

SYSTEMATIC REVIEW BISPECIFIC ANTIBODIES IN RELAPSED REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW OF EFFICACY AND SAFETY IN PHASE I/II/III CLINICAL TRIAL · Sankore